Singapore, Oct. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamid... Read More
Singapore, Oct. 3 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-08634... Read More
Singapore, Oct. 3 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy Wit... Read More
Singapore, Oct. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Vers... Read More
U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07853807) titled 'Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): ... Read More
U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07855692) titled 'The Clinical Trial of Tamibarotene for Patients With HFpEF (RELIEF Trial)' on Sept. 28. Bri... Read More
Singapore, Oct. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Vers... Read More
U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07854548) titled 'Wording Approaches to Convey the Strength of Recommendations in Health Guidelines' on Sept. ... Read More
Singapore, Oct. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety a... Read More
Singapore, Oct. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, double-blind, randomized, placebo controlled, 2-arm study to investigate the safety and ... Read More